0001127602-22-003279.txt : 20220204
0001127602-22-003279.hdr.sgml : 20220204
20220204094442
ACCESSION NUMBER: 0001127602-22-003279
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220202
FILED AS OF DATE: 20220204
DATE AS OF CHANGE: 20220204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kirchgraber Paul R
CENTRAL INDEX KEY: 0001791393
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11353
FILM NUMBER: 22591606
MAIL ADDRESS:
STREET 1: 531 SOUTH SPRING STREET
CITY: BURLINGTON
STATE: NC
ZIP: 27215
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS
CENTRAL INDEX KEY: 0000920148
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 133757370
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 358 S MAIN ST
CITY: BURLINGTON
STATE: NC
ZIP: 27215
BUSINESS PHONE: 3362291127
MAIL ADDRESS:
STREET 1: 358 S MAIN ST
CITY: BURLINGTON
STATE: NC
ZIP: 27215
FORMER COMPANY:
FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC
DATE OF NAME CHANGE: 19940314
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2022-02-02
0000920148
LABORATORY CORP OF AMERICA HOLDINGS
LH
0001791393
Kirchgraber Paul R
531 SOUTH SPRING STREET
BURLINGTON
NC
27215
1
CEO, Covance Drug Development
Common Stock
2022-02-02
4
M
0
443
A
9396
D
Common Stock
2022-02-02
4
F
0
144
273.18
D
9252
D
Restricted Stock Unit
2022-02-02
4
M
0
443
0
D
Common Stock
443
4331
D
Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
Stock withholding to satisfy tax withholding obligations.
The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 2, 2022.
This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
/s/ Sandra van der Vaart, Attorney-in-Fact for Paul R. Kirchgraber
2022-02-04